Creative Biolabs-Immuno-oncology

Anti-CDH2 (clone W3E4I) SynExpress pB-BF-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR744)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CDH2 (clone W3E4I). We employs the Adenovirus (pBAD-BFP-IL-4-KpnI) vector components and the SynExpress system of the Exons Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CDH2
Clone
W3E4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
pBAD
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Prime Editing
Modification Domain
Exons
Carrier Type
Adenovirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.